Dynamic MapReport

World News   USA   California   Bay Area   Peninsula   Central San Mateo County   Foster City   Gilead (13)
Foster City, Gilead Timeline Tuesday, April 24 Bookmark and Share     Author
Search Bay Area News Atlas:
Gilead Sciences beats Street 3Q forecasts  Propelled by sales of hepatitis C pills, Gilead posted an impressive 68% increase in third-quarter profit and hiked its revenue forecast yet again Gilead profit beats Wall Street forecasts
World News (12) World Business (847) USA (336) California (187) Bay Area (12) Bay Area Business (1699) Peninsula (1080) Central San Mateo County (175) Foster City (65) Gilead (13)
2017 (1) 2016 (1) 2015 (2) 2014 (2) 2011 (1) 2009 (3) 2003 (1) 2002 (2)
Foster City Gilead on Wikipedia Foster City Gilead on Web

Foster City Business (30)   Foster City 4th Quarter Earnings   Foster City Bio Tech (14)   Palo Alto Merger and Acquisition (47)   Palo Alto Business (143)
Gilead Sciences beats estimates for 4th-quarter earnings
Gilead beats Street 4Q forecasts


year 2017 Top ^

Feb.7
  Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $3.11 billion. It had profit of $2.34 per share


year 2016 Top ^

Feb.2
   34 percent increase in profit, trouncing expectations, as sales of its blockbuster hepatitis C drugs soared in Japan and offset lower sales in the U.S



year 2015 Top ^

Oct.27
Jul.28
  Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences’ second-quarter profit by 23% as total revenue for the biotech drugmaker jumped 26%


year 2014 Top ^

Mar.3 Gilead Sciences CEO joins billionaires' ranks
  John Martin is $1.2 billion, based on his stake in the company, which recently released a potential blockbuster drug to treat Hepatitis C Feb.5 Gilead profit beats estimates  Gilead Sciences Inc., the world's largest maker of HIV medicines, has reported net income in the fourth quarter rose 3.8 percent to $791.4 million

year 2011 Top ^

Nov.21 Gilead to buy Pharmasset for $11 billion
  Gilead Sciences Inc. has agreed to pay about $11 billion for drug developer Pharmasset Inc. in a huge bet on experimental hepatitis C treatments


year 2009 Top ^

Apr.28   Flu's bad news but shot in arm for Gilead
  Gilead Sciences climbed nearly 4 percent to close at $47.53; they're collecting on Tamiflu, the influenza drug the biotech company invented Apr.22 Lawsuit Vs. Gilead To Proceed
  The U.S. Supreme Court has refused to halt a securities-fraud suit by investors who claim the biotech company inflated its stock price in 2003 Mar.12 Gilead To Buy CV Therapeutics For $1.4 B
  Biotechnology company Gilead Sciences, known for its HIV drugs, said it will pay $20 per share in cash for Palo Alto-based CV Therapeutics


year 2003 Top ^

Apr.4 Company ships AIDS drug to Africa
  Gilead Sciences has begun shipping its new drug at cost to poor countries in Africa and other regions

year 2002 Top ^

Dec.17 Gilead to slash AIDS drug price in Africa  Gilead Sciences would dramatically slash the price it charges for Viread in all of Africa and 15 other least-developed countries Dec.4 Gilead buys AIDS-fighting competitor  Gilead Sciences would acquire Triangle Pharmaceuticals for $464 million in cash


Add a favorite (file a bookmark) to Foster City, Gilead Timeline

Please send feedback to: support@mapreport.com

Advertise on Foster City, Gilead Page


XML